|
Match
|
Document |
Document Title |
|
|
7067135 |
Methods and compositions for the treatment and prevention of Staphylococcus aureus infections
The invention features methods and compositions for treatment or prevention of infection by, or disease caused by infection with, Staphylococcus spp., particularly S. aureus.
|
|
|
6984381 |
Vaccine for the prevention of bacterial infection of the bovine mammary gland
A novel vaccine for immunizing animals against Staphylococcus aureus -induced mastitis is disclosed. The vaccine is comprised of whole killed cells of S. aureus in a dosage effective to immunize...
|
|
|
6846625 |
Method for identifying validated target and assay combination for drug development
The invention comprises methods useful within a larger process for identifying compounds and/or designing further compounds with activity to produce a desired phenotype (for example, growth...
|
|
|
6767536 |
Recombinant Staphylococcus thioredoxin reductase and inhibitors thereof useful as antimicrobial agents
Isolated and purified Staphylococcus thioredoxin reductases (TrxB) are provided. Polynucleotides encoding the TrxBs, vectors and host cells containing such polynucleotides are also provided. In...
|
|
|
6368590 |
Pharmaceutical preparation and method for treatment and prevention of fibromyalgia and chronic fatigue
Use of a staphylococcus bacteria or a product thereof for the manufacture of a pharmaceutical preparation for treatment and/or prevention of fibromylagia and chronic fatigue syndrome. Preferably,...
|
|
|
5840318 |
Methods and compositions for modulating immune systems of animals
Methods and compositions for modulating the immune system of animals by activating macrophages to release cytokines and down-regulating their sensitivity to bacterial endotoxin and to conversion to...
|
|
|
5770208 |
Staphylococcus aureus B-linked hexosamine antigen
A negatively-charged S. aureus antigen contains β-hexosamine as a major carbohydrate component. S. aureus strains that carry the antigen account for nearly all of the clinically significant...
|
|
|
5767090 |
Microbially produced rhamnolipids (biosurfactants) for the control of plant pathogenic zoosporic fungi
Disclosed is the use of biosurfactants as biological control products. In particular, rhamnolipid biosurfactants produced by Pseudomonas spp. were demonstrated to rapidly kill zoospores by...
|
|
|
5639659 |
Process for inhibiting the growth of bacteria using bacteriocins produced by Propionibacterium jensenii strain ATCC 4872
An anti-bacterial agent for controlling the growth of certain lactic acid bacteria is provided. The anti-bacterial agent, or bacteriocin, is produced by Propionibacterium jensenii, and specifically...
|
|
|
4670255 |
Hair tonic composition
A hair tonic composition containing, as an effective ingredient, a product obtained from the interaction of a vegetable or animal fat or oil with a microorganism belonging to Staphylococcus...
|
|
|
4565698 |
Microbial hair tonic composition
A microbial hair tonic composition containing, as an effective ingredient, cells belonging to species Staphylococcus capitis, or the crushed products, extracts, or cultured products thereof. This...
|
|
|
3655873 |
Title is not available
|